Skip to main content

2342 · TRANS GENIC GROUP INC. · Financials

203 JPY -26 (-11.35%) At close · Nov 13
Market Cap
3.38B JPY
Shares
16.65M
Volume · Nov 13 159.9K Avg daily vol (3M) 51.1K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
13.17B +1.3%
FY2026 Revenue FY2022–FY2026
Net Income
-77.27M +92.9%
FY2026 Net Income FY2022–FY2026
Gross Margin
18.47% +1.8pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
1.05% +3pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
25.91M -72.5%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 13.17B 13.01B 13.08B 11.43B 12.58B
JPY 10.74B 10.84B 10.83B 9.43B 8.74B
JPY 2.43B 2.17B 2.25B 1.99B 3.84B
JPY 137.96M -259.51M 89.44M -25.15M 1.84B
JPY -207.44M -675.96M 43.08M -331.81M 2.77B
JPY -109.98M 414.6M 39.09M 108.09M 907.68M
JPY -77.27M -1.09B 4.09M -409.67M 1.88B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 286.56M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.